Dr. Joan A. Steitz's lab at Yale University studies how certain viruses can manipulate their host cells using noncoding RNAs, which are special RNA molecules that don't make proteins but influence gene function. By investigating these noncoding RNAs associated with oncogenic herpesviruses such as Epstein-Barr virus and Kaposi's sarcoma-associated virus, the lab aims to uncover novel mechanisms of RNA behavior and its implications in cancer. Their research could lead to new therapeutic strategies to combat viral infections and related cancers.

Dr. Craig M. Crews leads a research lab at Yale University focused on innovative methods to treat diseases like Sickle Cell Disease (SCD) and certain cancers. His team explores new drugs that can degrade problematic proteins that contribute to these diseases, making it easier to target challenging medical conditions. By developing small molecules that induce the degradation of specific proteins, they aim to improve treatment effectiveness and create more targeted therapies.

Dr. Enrique M De La Cruz's lab at Yale University focuses on understanding the dynamics of actin filaments, which are crucial for cell movement and other essential processes in eukaryotic cells. The lab combines biochemical and biophysical techniques to explore how actin networks are built, remodeled, and recycled, and how these processes are regulated by various proteins. This research not only sheds light on fundamental cellular functions but also has implications for understanding diseases related to cell motility.

Dr. Stavroula Hatzios's lab at Yale University conducts research on how microbial infections contribute to cancer development. By focusing on oxidative stress, which is often caused by infections, they study how specific sites on proteins are modified and impact cellular functions. The lab utilizes innovative techniques to uncover these modifications, aiming to establish new therapeutic strategies to combat cancer linked to infections.

The Xiong laboratory at Yale University focuses on understanding the life cycle of HIV-1, particularly how the virus matures and enters the nucleus of host cells. By using advanced imaging techniques like cryo-electron microscopy, the lab investigates the structural changes that occur during the maturation of the HIV-1 capsid and how this process can be inhibited by certain drugs. Their research aims to advance our understanding of HIV-1 biology and contribute to the development of new anti-HIV therapies.

Scott Holley's lab at Yale University studies how the body of zebrafish develops, focusing on understanding the early stages of spinal column formation. Using zebrafish as a model organism, the research explores the mechanisms behind human developmental issues, such as scoliosis and spina bifida. The lab combines various techniques like genetics and live imaging to uncover how cells interact and organize during development, contributing to a more profound understanding of biological order and developmental stability.

Dr. Ailong Ke's lab at Yale University focuses on understanding the intricate roles of RNA in gene regulation and immunity using advanced techniques in biophysics and molecular genetics. The lab aims to develop new biotechnological applications, including RNA-based genome editing tools like CRISPR. By studying the structure and function of riboswitches, the research also seeks to identify new antibiotic targets relevant to human health.

Dr. Anthony Koleske's lab at Yale University focuses on understanding the role of the TRIO gene in neurodevelopmental disorders like autism and schizophrenia. The lab investigates how specific genetic variants affect TRIO protein function and aims to identify small molecules to modulate its activity as potential therapeutic strategies. Through biochemical assays and advanced cell models, the lab seeks to elucidate the underlying mechanisms of neuronal development influenced by TRIO.

Dr. Julien Berro's lab explores how physical forces impact cellular processes such as endocytosis, which is how cells take in nutrients and communicate. By developing innovative force sensors and protein engineering techniques, the lab aims to understand the mechanics behind these processes at a molecular level. This research could lead to new therapeutic strategies for diseases like cancer and metabolic disorders by leveraging mechanical signals to influence cell behavior.

Dr. Michael Koelle's lab at Yale University focuses on understanding how brain circuits work by studying the egg-laying behavior in the tiny roundworm C. elegans. The lab aims to pinpoint how various signaling molecules like neurotransmitters and neuropeptides contribute to the activity of these circuits, which can provide insights into human brain diseases. By using advanced techniques such as imaging and genetics, the lab investigates the interactions of different neurons and how they govern behavior.

Farren J. Isaacs' lab at Yale University focuses on understanding how proteins interact with each other and how their functions are modified by chemical changes called post-translational modifications (PTMs). By engineering bacteria to produce proteins with specific modifications, the lab aims to uncover the role of these modifications in crucial cellular processes and disease states. This pioneering work could lead to the development of new therapeutic strategies targeting diseases linked to protein interactions.

Dr. Susan Baserga's lab at Yale University focuses on understanding the process of ribosome biogenesis and its links to human genetic diseases. They utilize innovative approaches, including genome-wide screening techniques, to identify proteins and non-coding RNAs that regulate ribosome production. By investigating how these processes affect cellular function in various tissues and during development, the lab aims to uncover the foundations of ribosomopathies, which are disorders tied to abnormal ribosome function.

Dr. Thierry Emonet's lab at Yale University studies how bacteria navigate through their environments using a process called chemotaxis. They are particularly interested in how different species of bacteria, like E. coli and Vibrio cholerae, respond to chemical signals and how these responses affect their ability to move collectively. By understanding these behaviors, the lab aims to provide insights into bacterial infections and the dynamics of microbial populations.

Dr. Nadya Dimitrova's lab at Yale University studies the role of long noncoding RNAs (lncRNAs), particularly Malat1, in lung adenocarcinoma (LUAD). They focus on how Malat1 contributes to cancer progression and the tumor microenvironment, using advanced mouse models and molecular biology techniques. The lab aims to uncover potential therapeutic targets by understanding how the deregulation of lncRNAs affects cancer development.